TransMedics Group, Inc.·4

Aug 9, 4:30 PM ET

Ranganath Anil P. 4

4 · TransMedics Group, Inc. · Filed Aug 9, 2024

Insider Transaction Report

Form 4
Period: 2024-06-05
Transactions
  • Exercise/Conversion

    Common Stock

    2024-08-07$93.88/sh+4,289$402,65113,182 total
  • Sale

    Common Stock

    2024-08-07$152.20/sh4,289$652,7868,893 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-08-074,28910,420 total
    Exercise: $93.88Exp: 2033-08-01Common Stock (4,289 underlying)
  • Sale

    Common Stock

    2024-06-05$135.21/sh703$95,0538,809 total
Footnotes (3)
  • [F1]Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction pursuant to the terms of the RSU award.
  • [F2]Includes 84 shares of Issuer's Common Stock acquired on June 28, 2024, pursuant to the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan ("ESPP"), for the option period of January 2, 2024 to June 28, 2024. This transaction is exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's Common Stock on January 2, 2024.
  • [F3]The option vested as to 25% on June 5, 2024 and will vest as to the remaining shares in equal monthly installments over three years thereafter, subject to continued service.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4